Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Wednesday, March 4, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Authors
Posts by Life Sciences Times
Life Sciences Times
8044 POSTS
0 Comments
https://blstimes.com
Venture Capital
Cirtec Medical Announces Acquisition of NovelCath
Life Sciences Times
-
December 17, 2020
0
Venture Capital
Verily Announces $700 Million Investment Round to Accelerate Key Businesses, Including Baseline and Verily Health Platforms
Life Sciences Times
-
December 17, 2020
0
Venture Capital
ECS Awarded $28.8 Million USMC IT Service and Support Contract
Life Sciences Times
-
December 17, 2020
0
Medtech
Cedar Gate Technologies Acquires Lexington-Based Deerwalk
Life Sciences Times
-
December 17, 2020
0
Biotech
Ginkgo Bioworks Acquires Biotechnology Startup Novogy
Life Sciences Times
-
December 17, 2020
0
Medtech
Carlsmed Raises $10 Million to Commercialize Aprevo Devices
Life Sciences Times
-
December 17, 2020
0
Medtech
Amalgam Rx Appoints New President: Chris Bergstrom,
Life Sciences Times
-
December 17, 2020
0
Biotech
Virios Therapeutics Announces Pricing of Initial Public Offering
Life Sciences Times
-
December 17, 2020
0
Public Health
NZ to purchase Covid-19 vaccines enough for every citizen: PM
Life Sciences Times
-
December 17, 2020
0
Pharma
Extra Pfizer vaccine doses can be used: FDA tells pharmacists
Life Sciences Times
-
December 17, 2020
0
1
...
797
798
799
...
805
Page 798 of 805
TOP AUTHORS
Life Sciences Times
8044 POSTS
0 Comments
https://blstimes.com
Most Read
Mobile Heartbeat Expands Banyan Platform Integration With Microsoft Teams to Improve Enterprise Communication
March 3, 2026
Syntis Bio Doses First Patient in Phase 1/1b Trial of Oral Obesity Drug SYNT-101, Expands Leadership Team
March 3, 2026
Poplar Therapeutics Raises $45 Million to Advance Anti-IgE Therapy for Food Allergy and Atopic Diseases
March 3, 2026
Amylyx Pharmaceuticals Narrows Losses in 2025 as Phase 3 Avexitide Trial Nears Completion
March 3, 2026